Advancing the pharmacological treatment of bipolar depression

Advances in Psychiatric Treatment

Volumn 11, Issue 1, 2005, Pages 28-37

  Frangou, Sophia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CLOZAPINE; DESIPRAMINE; IMIPRAMINE; LAMOTRIGINE; LITHIUM; MOCLOBEMIDE; MOOD STABILIZER; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; VALPROIC ACID; VALPROMIDE; VENLAFAXINE;

ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EVIDENCE BASED MEDICINE; EXPERIENCE; HUMAN; MANIA; MEDICAL RESEARCH; MEDICATION ERROR; MENTAL HEALTH CARE; MORBIDITY; MORTALITY; SOCIAL DISABILITY;

EID: 11444249746     PISSN: 13555146     EISSN: None     Source Type: Journal    
DOI: 10.1192/apt.11.1.28     Document Type: Article

References (73)

1. Akiskal, H. S. & Benazzi, R (2004) Validating Kraepelin's two types of depressive mixed states: "depression with flight of ideas" and "excited depression". World Journal of Biological Psychiatry, 5, 107-113.
2. Akiskal, H. S., Coryell, W., Leon, A. C., et al (1994) The time course of nonchronic major depressive disorder. Uniformity across episodes and samples. National Institute of Mental Health Collaborative Program on the Psychobiology of Depression - Clinical Studies. Archives of General Psychiatry, 51, 405-410.
3. Altamura, A. C., Salvadori, D., Madaro D., et al (2003) Efficacy and tolerability of quetiapine in the treatment of bipolar disorder: preliminary evidence from a 12-month open-label study. Journal of Affective Disorders, 76, 267-271.
4. Altshuler, L., Suppes, T., Black, D., et al (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. American Journal of Psychiatry, 160, 1252-1262.
5. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) (4th edn). Washington, DC: APA.
6. American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159 (suppl. 4), 1-50.
7. Angst, J., Gamma, A., Benazzi, F., et al (2003) Diagnostic issues in bipolar disorder. European Neuropsychopharmacology, 13 (suppl. 2), S43-50.
8. Baldessarini, R. J., Tondo, L. & Hennen, J. (2003) Lithium treatment and suicide risk in major affective disorders: update and new findings. Journal of Clinical Psychiatry, 64 (suppl. 5), 44-52.
9. Ballenger, J. C. & Post, R. M. (1980) Carbamazepine in manic-depressive illness: a new treatment. American Journal of Psychiatry, 137, 782-790.
10. Baron, M., Gershon, E. S., Rudy, V., et al (1975) Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Archives of General Psychiatry, 32, 1107-1111.
11. Bauer, M. S. & Mitchner, L. (2004) What is a "mood stabilizer"? An evidence-based response. American Journal of Psychiatry, 161, 3-18.
12. Baumhackl, U., Bizière K., Fischbach R., et al (1989) Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. British Journal of Psychiatry, 155 (suppl. 6), 785-835.
13. Bowden, C. L., Calabrese, J. R., McElroy, S. L., et al (2000) A randomized, placebo-controlled 12-month trial of valproate and lithium in treatment of outpatients with bipolar I disorder. Valproate Maintenance Study Group. Archives of General Psychiatry, 57, 481-489.
14. Bowden, C. L., Calabrese, J. R., Sachs, G., et al (2003) Lamictal 606 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry, 60, 392-400.
15. Calabrese, J. R., Markovitz, P. J., Kimmel, S. E., et al (1992) Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. Journal of Clinical Psychopharmacology, 12 (suppl. 1), 535-565.
16. Calabrese, J. R., Bowden, C. L., McElroy, S. L., et al (1999a) Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. American Journal of Psychiatry, 156, 1019-1023.
17. Calabrese, J. R., Bowden, C. L., Sachs, G. S., et al (1999b) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. Journal of Clinical Psychiatry, 60, 79-88.
18. Calabrese, J. R., Bowden, C. L., Sachs, G. S., et al (2003) Lamictal 605 Study Group. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry, 64, 1013-1024.
19. Ciapparelli, A., Dell'Osso, L., Bandettini di Poggio, A., et al (2003) Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study. Journal of Clinical Psychiatry 64, 451-458.
20. Cohn, J. B., Collins, G., Ashbrook E., et al (1989) A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. International Clinical Psychopharmacology, 4, 313-322.
21. Collaborative Working Group on Clinical Trial Evaluations (1998) Atypical antipsychotics for treatment of depression in schizophrenia and affective disorders. Journal of Clinical Psychiatry 59 (suppl. 12), 41-45.
22. Dickerson, F. B., Boronow, J. J., Stallings, C. R., et al (2004) Association between cognitive functioning and employment status of persons with bipolar disorder. Psychiatric Services (Washington, D.C.), 55, 54-58.
23. Fieve, R. R., Platman, S. R. & Plutchik, R. R. (1968) The use of lithium in affective disorders. I: Acute endogenous depression. American Journal of Psychiatry, 125, 487-491.
24. Geddes, J. R., Burgess, S., Hawton, K., et al (2004) Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry, 16, 217-222.
25. Ghaemi, S. N. & Goodwin, F. K. (2001) Long-term naturalistic treatment of depressive symptoms in bipolar illness with valproate vs. lithium in the setting of minimal antidepressant use. Journal of Affective Disorders, 65, 281-287.
26. Ghaemi, S. N., Sachs, G. S., Chiou, A. M., et al (1999) Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? Journal of Affective Disorders, 52, 135-144.
27. Ghaemi, S. N., Rosenquist, K. J., Ko, J. Y., et al (2004) Antidepressant treatment in bipolar versus unipolar depression. American Journal of Psychiatry, 161, 163-165.
28. Goodwin, G. M. (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 17, 149-173.
29. Goodwin, F. K., Fireman, B., Simon, G. E., et al (2003) Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA, 290, 1467-1473.
30. Greil, W., Ludwig-Mayerhofer, W., Erazo, N., et al (1997) Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study. Journal of Affective Disorders 43, 151-161.
31. Gyulai, L., Bowden, C. L., McElroy, S. L., et al (2003) Maintenance efficacy of valproate in the prevention of bipolar depression. Neuropsychopharmacology, 28, 1374-1382.
32. Hantouche, E. G., Akiskal, H. S., Lancrenon, S., et al (1998) Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multisite study (EPIDEP). Journal of Affective Disorders, 50, 163-173.
33. Harrow, M., Goldberg, J. F., Grossman, L. S., et al (1990) Outcome in manic disorders. A naturalistic follow-up study. Archives of General Psychiatry, 47, 665-671.
34. Himmelhoch, J. M., Thase, M. E., Mallinger, A. G., et al (1991) Tranylcypromine versus imipramine in anergic bipolar depression. American Journal of Psychiatry, 148, 910-916.
35. Isometsa, E. T., Henriksson, M. M., Aro, H. M., et al (1994) Suicide in bipolar disorder in Finland. American Journal of Psychiatry, 151, 1020-4102.
36. Judd, L. L., Akiskal, H. S., Schettler, P. J., et al (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry, 59, 530-537.
37. Judd, L. L., Akiskal, H. S., Schettler, P. J., et al (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Archives of General Psychiatry, 60, 261-269.
38. Keller, M. B. (1988) The course of manic-depressive illness. Journal of Clinical Psychiatry, 49 (suppl.), 4-7.
39. Kessler, R. C., McGonagle, K. A., Zhao, S., et al (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19.
40. Kessler, R. C., Rubinow, D. R., Holmes, C., et al (1997) The epidemiology of DSM-III-R bipolar I disorder in general population survey. Psychological Medicine, 27, 1079-1089.
41. Lambert, P. A. & Venaud, G. (1992) Comparative study of valpromide versus lithium in treatment of affective disorders. Nervure: Journal de Psychiatrie, 5, 57-65.
42. Leverich, G. S., Altshuler, L. L., Frye, M. A., et al (2003) Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. Journal of Clinical Psychiatry, 64, 506-15.
43. Lish, J. D., Dime-Meenan, S., Whybrow, P, C., et al (1994) The National Depressive and Manic-Depressive Association (DMDA) survey of bipolar members. Journal of Affective Disorders, 31 281-294.
44. MacQueen, G. M., Glenda, M., Young, L., et al (2001) A review of psychosocial outcome in patients with bipolar disorder. Acta Psychiatrica Scandinavica, 103, 163-170.
45. Mitchell, P. B., Wilhelm, K., Parker, G., et al (2001) The clinical features of bipolar depression: a comparison with matched major depressive disorder patients. Journal of Clinical Psychiatry, 62, 212-216.
46. Nemeroff, C. B., Evans, D. L., Gyulai, L., et al (2001) Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry 58, 906-912.
47. Noyes, R., Dempsey, G. M., Blum, A., et al (1974) Lithium treatment in depression. Comprehensive Psychiatry, 15 187-193.
48. Okuma, T., Inanaga, K., Otsuki, S., et al (1981) A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology, 73 95-96.
49. Patsalos, P. N. & Perucca, E. (2003) Clinically important drug interaciions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurology, 2, 473-481.
50. Peet, M. (1994) Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. British Journal of Psychiatry, 164, 549-550.
51. Post, R. M., Uhde, T. W., Ballenger, J. C., et al (1983) Carbamazepine and its - 10,11-epoxide metabolite in plasma and CSF: relationship to antidepressant response. Archives of General Psychiatry, 1983, 40, 673-676.
52. Post, R. M., Uhde, T. W., Roy-Byrne, P. P., et al (1986) Antidepressant effects of carbamazepine. The American Journal of Psychiatry, 143, 29-34.
53. Post, R. M., Altshuler, L. L., Frye, M. A., et al (2001a) Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers. Bipolar Disorders, 3, 259-265.
54. Post, R. M., Nolen, W. A., Kupka, R. W, et al (2001b The Stanley Foundation Bipolar Network. I. Rationale and methods. British Journal of Psychiatry, 178 (suppl. 41), s169-s176.
55. Post, R. M., Leverich, G. S., Nolen, W. A., et al (2003) A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disorders, 5, 396-406.
56. Prien, R. F., Caffey, E. M. Jr. & Klett, C. J. (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness: report of the Veteran's Administration and National Institute of Mental Health collaborative study group. Archives of General Psychiatry, 28, 337-341.
57. Prien, R. F., Klett, C. J. & Caffey, E. M. (1974) Lithium prophylaxis in recurrent affective illness. American Journal of Psychiatry, 131, 198-203.
58. Quraishi, S. & Frangou, S. (2002) Neuropsychology of bipolar disorder: a review. Journal of Affective Disorder, 72, 209-226.
59. Raymont, V., Bettany, D. & Frangou, S. (2003) The Maudsley bipolar disorder project. Clinical characteristics of bipolar disorder I in a Catchment area treatment sample. European Psychiatry, 18 13-17.
60. Regier, D. A., Farmer, M. E. & Rae, D. S. (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264, 2511-2518.
61. Sachs, G. S., Lafer, B., Stoll, A. L., et al (1994) A double-blind trial of bupropion versus desipramine for bipolar depression. Journal of Clinical Psychiatry, 55, 391-393.
62. Simpson, S. G. & DePaulo, J. R. (1991) Fluoxetine treatment of bipolar II depression. Journal of Clinical Psychopharmacology, 11, 52-54.
63. Sokolski, K. N. & Denson, T. F. (2003) Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 27 863-866.
64. Stokes, P, E., Shamoian, C. A., Stoll, P. M., et al (1971) Efficacy of lithium as acute treatment of manic-depressive illness. Lancet, 1, 319-325.
65. Thase, M. E., Mallinger, A. G., McKnight, D., et al (1992) Treatment of imipramine-resistant recurrent depression. IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression. American Journal of Psychiatry, 149, 195-198.
66. Thies-Flechtner, K., Muller-Oerlinghausen, B., Seibert, W., et al (1996) Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry, 29, 103-107.
67. Tohen, M., Vieta, E., Calabrese, J., et al (2003) Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Archives of General Psychiatry, 60, 1079-1088.
68. Vieta, E., Goikolea, J. M., Corbella, B., et al, (2001) Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study. Journal of Clinical Psychiatry, 62, 818-825.
69. World Health Organization (1992) The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
70. Worrall, E. P., Moody, J. P., Peet, M., et al (1979) Controlled studies of the acute antidepressant effects of lithium. British Journal of Psychiatry, 135, 255-262.
71. Yatham, L. N., Srisurapanont, M., Zis, A. P., et al (1997) Comparative studies of the biological distinction between unipolar and bipolar depressions. Life Science, 61, 1445-1455.
72. Young, L. T., Joffe, R. T., Robb, J. C., et al (2000) Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. American Journal of Psychiatry, 157, 124-126.
73. Zarate, C. A. Jr., Tohen, M. & Baldessarini, R. J. (1995) Clozapine in severe mood disorders. Journal of Clinical Psychiatry, 56, 411-417.